– Reuters
Truist Securities Initiates Coverage On Inari Medical with Hold Rating, Announces Price Target of $87
Truist Securities analyst Richard Newitter initiates coverage on Inari Medical (NASDAQ:NARI) with a Hold rating and announces Price Target of $87.